Product image of Myleugyne L.P (Econazole Nitrate) supplied by GNH India

Myleugyne L.P

Active Ingredient:
Econazole Nitrate
Origin:
EU

Myleugyne L.P (Econazole Nitrate)

Econazole Nitrate, the active ingredient in Myleugyne L.P, is an imidazole antifungal presented as a vaginal tablet for intravaginal use. It is indicated for the treatment of vulvovaginal candidiasis, a common yeast infection affecting women, by inhibiting fungal cell membrane synthesis and restoring normal vaginal flora. The product conforms to EU quality standards and is manufactured under strict GMP conditions.

GNH India supplies Myleugyne L.P as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Iprad

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Econazole Nitrate is an imidazole antifungal used to treat fungal infections of the vaginal mucosa.

  • Vulvovaginal candidiasis: relieves symptoms such as itching, discharge and irritation while eradicating Candida species from the vaginal environment.

How It Works

  • Econazole Nitrate inhibits the fungal enzyme lanosterol 14α‑demethylase, a key step in ergosterol synthesis. By blocking this pathway, the drug disrupts the formation of the fungal cell membrane, leading to increased membrane permeability and ultimately fungal cell death, while having minimal effect on human cells.

Side Effects

Econazole Nitrate may cause local adverse reactions when applied intravaginally.

Common Side Effects

  • Vaginal irritation: mild burning or stinging sensation.
  • Itching: localized pruritus at the application site.
  • Discharge: increased vaginal secretions, often watery.
  • Redness: erythema of the vaginal walls.
  • Unpleasant odor: temporary change in vaginal scent.
  • Mild discomfort: sensation of pressure or fullness.

Serious or Rare Side Effects

  • Allergic reaction: rash, hives, or swelling of the face and throat.
  • Severe dermatitis: extensive skin inflammation beyond the vaginal area.
  • Anaphylaxis: rapid onset of breathing difficulty and hypotension.
  • Persistent ulceration: non‑healing sores in the vaginal mucosa.
  • Systemic toxicity: rare signs such as nausea, vomiting, or dizziness.
  • Secondary infection: overgrowth of non‑Candida organisms.

Precautions & Warnings

Before using Myleugyne L.P, consider the following safety measures.

  • Pregnancy: consult a healthcare professional before use, as safety data are limited.
  • Breastfeeding: discuss potential risks with a physician, especially if the infant is preterm.
  • Allergy: avoid if known hypersensitivity to econazole or other imidazoles exists.
  • Concurrent vaginal products: do not use other intravaginal medications simultaneously without medical advice.
  • Complete therapy: finish the prescribed course even if symptoms improve early.
  • Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Econazole Nitrate may interact with other medications when used intravaginally.

Major Interactions (Avoid)

  • Systemic azole antifungals: concurrent use can increase systemic exposure and risk of toxicity.
  • Topical corticosteroids: may mask local irritation and delay detection of adverse reactions.

Moderate Interactions (Monitor Closely)

  • Oral contraceptives: possible reduction in efficacy, advise additional contraceptive measures.
  • Antihistamines: may diminish perception of itching, requiring closer symptom monitoring.
  • Other vaginal medications: assess compatibility to prevent additive irritation.
  • Herbal suppositories: monitor for unexpected local effects.

Frequently Asked Questions

Myleugyne L.P contains econazole nitrate and is used to treat vulvovaginal candidiasis, a yeast infection of the vagina. The medication is applied intravaginally to relieve symptoms such as itching, burning, and abnormal discharge while eliminating the Candida organisms responsible for the infection.

Econazole nitrate belongs to the imidazole class of antifungals. It blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for synthesising ergosterol, a key component of the fungal cell membrane. Disruption of ergosterol production compromises membrane integrity, leading to fungal cell death.

The specific dosing regimen for Myleugyne L.P is determined by the prescribing healthcare professional based on the severity of infection and patient characteristics. Patients should follow the prescriber’s instructions and complete the full course of therapy to ensure effective treatment.

Safety data for econazole nitrate in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Myleugyne L.P.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Myleugyne L.P delivers econazole nitrate, an imidazole antifungal, whereas many alternatives such as clotrimazole or miconazole belong to the same class but differ in potency, formulation and resistance profiles. Econazole offers a broad spectrum against Candida species and is formulated for intravaginal delivery, providing targeted therapy with minimal systemic exposure.

Store Myleugyne L.P at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and extreme temperatures to maintain stability and efficacy.

Myleugyne L.P is administered intravaginally. The tablet is inserted into the vagina according to the prescriber’s instructions, typically using a clean applicator or fingertip, and left in place for the prescribed duration before removal or dissolution.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, extensive dermatitis, and secondary infections. Patients should seek immediate medical attention if they experience swelling of the face or throat, difficulty breathing, or persistent severe irritation.

Myleugyne L.P should not be used by individuals with a known hypersensitivity to econazole nitrate or any other imidazole antifungal. It is also contraindicated in patients who are currently using incompatible intravaginal products without medical guidance.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.